FDA Approves Two New Treatments for Diarrhea-Predominant IBS (FREE)

By Kristin J. Kelley Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS Eluxadoline (Viberzi) and rifaximin (Xifaxan) have both been approved to treat irritable bowel syndrome with diarrhea. The approvals …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news